Cost reductive use of erythropoietin in patients with myelodysplasia.
Publication
, Conference
Patterson, SG; Benson, K; Balducci, L; Extermann, M; Lyman, GH; Lee, H
Published in: BLOOD
1997
Duke Scholars
Published In
BLOOD
ISSN
0006-4971
Publication Date
1997
Volume
90
Issue
10
Start / End Page
3324 / 3324
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Patterson, S. G., Benson, K., Balducci, L., Extermann, M., Lyman, G. H., & Lee, H. (1997). Cost reductive use of erythropoietin in patients with myelodysplasia. In BLOOD (Vol. 90, pp. 3324–3324).
Patterson, S. G., K. Benson, L. Balducci, M. Extermann, G. H. Lyman, and H. Lee. “Cost reductive use of erythropoietin in patients with myelodysplasia.” In BLOOD, 90:3324–3324, 1997.
Patterson SG, Benson K, Balducci L, Extermann M, Lyman GH, Lee H. Cost reductive use of erythropoietin in patients with myelodysplasia. In: BLOOD. 1997. p. 3324–3324.
Patterson, S. G., et al. “Cost reductive use of erythropoietin in patients with myelodysplasia.” BLOOD, vol. 90, no. 10, 1997, pp. 3324–3324.
Patterson SG, Benson K, Balducci L, Extermann M, Lyman GH, Lee H. Cost reductive use of erythropoietin in patients with myelodysplasia. BLOOD. 1997. p. 3324–3324.
Published In
BLOOD
ISSN
0006-4971
Publication Date
1997
Volume
90
Issue
10
Start / End Page
3324 / 3324
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology